With No Cure In Sight, Drugs Firm LianBio Begins Exit Strategy [Seeking Alpha]
LianBio (LIAN)
Company Research
Source: Seeking Alpha
The drug maker will sell its remaining pipeline assets, phase out ongoing clinical trials and pay a special dividend of $4.80 per share. LianBio has failed to deliver any product to the market since it was established in 2020. LianBio NASDAQ: LIAN ) was a rising star of the Chinese pharmaceutical scene but the drugs startup has flamed out just four years after its launch. The biotech's abbreviated lifespan underscores the challenges and costs of bringing novel drugs to the market, even with financial backing and big ambitions. The company's mission was to obtain the rights to drugs in the latter stages of development and make them available to the mass Chinese market. LianBio was the poster child of this so-called “licensing in” model, obtaining financing of $310 million just two months after the company was set up in 2020. A year later it went public on the Nasdaq, raising another $325 million. But after a strategic review of its business, LianBio announced last Tuesday th
Show less
Read more
Impact Snapshot
Event Time:
LIAN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LIAN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LIAN alerts
High impacting LianBio news events
Weekly update
A roundup of the hottest topics
LIAN
News
- LianBio Announces Voluntarily Delisting from Nasdaq [Yahoo! Finance]Yahoo! Finance
- LianBio Announces Voluntarily Delisting from NasdaqGlobeNewswire
- LianBio Shares Gain After Co Announces Plans to Wind Down [MarketWatch]MarketWatch
- LianBio to Wind Down Operations, Declares Special Dividend [MarketWatch]MarketWatch
- LianBio Announces Completion of Strategic Review [Yahoo! Finance]Yahoo! Finance
LIAN
Sec Filings
- 3/13/24 - Form EFFECT
- 3/12/24 - Form F-6
- 3/12/24 - Form S-8
- LIAN's page on the SEC website